Adriane V Rosario

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

D. Goldenberg, H. Hansen, I. Horak, 2004, Clinical Cancer Research.

Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.

D. Goldenberg, R. Michel, M. J. Mattes, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.

D. Goldenberg, H. Hansen, I. Horak, 2004, Blood.

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.

D. Goldenberg, R. Michel, M. J. Mattes, 2005, Nuclear medicine and biology.

Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74.

M. Brechbiel, D. Goldenberg, R. Michel, 2003, Nuclear medicine and biology.

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

D. Goldenberg, H. Hansen, I. Horak, 2004, Clinical Cancer Research.